Switch theme
Sign up to access all valuation multiples
Sinohealth is a leading provider of Big Data and artificial intelligence-based marketing and distribution information tools, including SaaS-based customer relationship management solutions to mainland China medical product manufacturers. It sources retail data through pharmacy partnerships and provides data analysis to the pharmaceutical and corporate clients it serves. Since its establishment in 2007, its focus has been on building a strong Big Data engine and networking capabilities to assist clients in their product investments and sales and marketing strategies. It is now launching various cloud-based systems and platform solutions for its clients and expanding its SaaS products, which are expected to be the key growth driver in future.
2019
759
LTM Revenue $59.7M
LTM EBITDA n/a
$96.6M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Sinohealth Holdings has a last 12-month revenue of $59.7M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Sinohealth Holdings achieved revenue of $51.0M and an EBITDA of $15.4M.
Sinohealth Holdings expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Sinohealth Holdings valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $45.9M | $51.0M | XXX | XXX | XXX |
| Gross Profit | $24.8M | $20.5M | XXX | XXX | XXX |
| Gross Margin | 54% | 40% | XXX | XXX | XXX |
| EBITDA | $8.2M | $15.4M | XXX | XXX | XXX |
| EBITDA Margin | 18% | 30% | XXX | XXX | XXX |
| Net Profit | $10.1M | $7.2M | XXX | XXX | XXX |
| Net Margin | 22% | 14% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Sinohealth Holdings's stock price is HKD 3 (or $0).
Sinohealth Holdings has current market cap of HKD 1.3B (or $172M), and EV of HKD 751M (or $96.6M).
See Sinohealth Holdings trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $96.6M | $172M | XXX | XXX | XXX | XXX | $0.04 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Sinohealth Holdings has market cap of $172M and EV of $96.6M.
Sinohealth Holdings's trades at 1.7x LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Sinohealth Holdings's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Sinohealth Holdings and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $96.6M | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 6.3x | XXX | XXX | XXX |
| P/E | 13.1x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 9.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSinohealth Holdings's NTM/LTM revenue growth is -100%
Sinohealth Holdings's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $20K for the same period.
Over next 12 months, Sinohealth Holdings's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Sinohealth Holdings's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Sinohealth Holdings and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 30% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 89% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $20K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 9% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 15% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 29% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Beamtree | XXX | XXX | XXX | XXX | XXX | XXX |
| Cogstate | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| Impedimed | XXX | XXX | XXX | XXX | XXX | XXX |
| Proteomics International | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sinohealth Holdings acquired XXX companies to date.
Last acquisition by Sinohealth Holdings was XXXXXXXX, XXXXX XXXXX XXXXXX . Sinohealth Holdings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Sinohealth Holdings founded? | Sinohealth Holdings was founded in 2019. |
| Where is Sinohealth Holdings headquartered? | Sinohealth Holdings is headquartered in Hong Kong. |
| How many employees does Sinohealth Holdings have? | As of today, Sinohealth Holdings has 759 employees. |
| Is Sinohealth Holdings publicy listed? | Yes, Sinohealth Holdings is a public company listed on HKG. |
| What is the stock symbol of Sinohealth Holdings? | Sinohealth Holdings trades under 02361 ticker. |
| When did Sinohealth Holdings go public? | Sinohealth Holdings went public in 2022. |
| Who are competitors of Sinohealth Holdings? | Similar companies to Sinohealth Holdings include e.g. Beamtree, Cogstate, Echo IQ, Impedimed. |
| What is the current market cap of Sinohealth Holdings? | Sinohealth Holdings's current market cap is $172M |
| What is the current revenue of Sinohealth Holdings? | Sinohealth Holdings's last 12-month revenue is $59.7M. |
| What is the current EV/Revenue multiple of Sinohealth Holdings? | Current revenue multiple of Sinohealth Holdings is 1.7x. |
| What is the current revenue growth of Sinohealth Holdings? | Sinohealth Holdings revenue growth between 2023 and 2024 was 11%. |
| Is Sinohealth Holdings profitable? | Yes, Sinohealth Holdings is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
